Objective (OCL) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
26 Feb, 2026Executive summary
Achieved 100% subscription-based software revenue, with SaaS revenue up 24% and adjusted EBITDA margin at 40% for the half-year.
Revenue reached $67 million, up 9% year-over-year, with ARR at $120 million (+12%) and net profit after tax of $19 million, up 10%.
Strong R&D investment at 28% of software revenue, totaling $17 million for the period and $140 million over five years.
Operating cash flow was $22 million, up 72% year-over-year, and cash balance at period end was $95 million.
Integration of IsoPlan and Isovist acquisitions expanded product offerings and market reach.
Financial highlights
Adjusted EBITDA was $26 million, up 11% year-over-year, with a margin of 40%.
Interim dividend of $0.13 per share declared, unfranked, up 13% from prior period.
Cash balance of $95 million after dividends and acquisitions; no external borrowings.
Operating cash flow increased 72% to $22 million.
Earnings per share rose to 19.6 cents from 17.9 cents year-over-year.
Outlook and guidance
FY2026 ARR growth guidance of 10–14% on a constant currency basis, targeting 15% through organic growth and R&D.
Continued strong EBITDA margin expected, leveraging AI leadership and expanding use cases.
R&D investment expected to remain stable, using AI efficiencies to accelerate innovation.
Focus remains on organic growth, with M&A activity paused pending market valuation adjustments.
Modest contribution from Objective Build in Australia expected in FY2026, with stronger impact anticipated in FY2027.
Latest events from Objective
- Revenue and profit surged, driven by SaaS and ARR growth, with a strong international outlook.OCL
H2 202423 Jan 2026 - Strong growth, SaaS transition, and key approvals defined the 2024 AGM.OCL
AGM 202412 Jan 2026 - Revenue, ARR, and profit grew, with strong SaaS, cash, and global expansion momentum.OCL
H1 202523 Dec 2025 - Strong recurring revenue growth, high R&D investment, and strategic AI-driven expansion highlighted.OCL
AGM 202525 Nov 2025 - ARR up 15% to AUD 120m, strong SaaS growth, and Isovist acquisition drive FY2026 outlook.OCL
H2 202523 Nov 2025